Scott A. Turner

University of San Diego — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index813citations69works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(10), Bladder and Urothelial Cancer Treatments(8), Fibroblast Growth Factor Research(7), Nuclear reactor physics and engineering(6), Nuclear Physics and Applications(5)

Publications69 total

485 Reassessing MRD detection: SPEP and IFE outperform routine bone marrow diagnostic studies in resource-limited settings
American Journal of Clinical Pathology·2025Open Access
A method to use X-ray computed tomography for measuring perfusable, high-resolution 3D-printed hydrogel structures
MRS Communications·2025Open Access
Time to Percutaneous Drain Placement and Impact on Patient Outcomes
Surgical Infections·2025
P862: Discordant cell-free DNA screening and ultrasound results aid prenatal diagnosis of androgen insensitivity syndrome
Genetics in Medicine Open·2025Open Access
Cutaneous Rosai–Dorfman disease with <i>MAP2K1</i> mutation, initially mimicking an infection with parasitized histiocytes
Journal of Cutaneous Pathology·2024· 2 citedOpen Access
Capabilities Toward Trustable AI/ML Pose Estimation for Satellite-to-Satellite Imagery
2024
P615: Low rate of clinical follow-up for potential germline variants identified in hematologic malignancies with a next generation sequencing panel
Genetics in Medicine Open·2024Open Access
Minimal Residual Disease Testing in Solid Tumors
Advances in Molecular Pathology·2023· 1 cited
Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
Cancers·2023· 6 citedOpen Access
Supplementary Figure Legend from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with &lt;i&gt;FGFR3&lt;/i&gt; Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
2023Open Access
Supplementary Figure Legend from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with &lt;i&gt;FGFR3&lt;/i&gt; Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
2023Open Access
Supplementary Table S1 from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with &lt;i&gt;FGFR3&lt;/i&gt; Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
2023Open Access
Supplementary Table S3 from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with &lt;i&gt;FGFR3&lt;/i&gt; Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
2023Open Access
Supplementary Table S3 from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with &lt;i&gt;FGFR3&lt;/i&gt; Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
2023Open Access
Supplementary Table S2 from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with &lt;i&gt;FGFR3&lt;/i&gt; Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
2023Open Access
Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs
Cancers·2023· 13 citedOpen Access
Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines
Journal of Molecular Diagnostics·2022· 36 cited
The basics of commonly used molecular techniques for diagnosis, and application of molecular testing in cytology
Diagnostic Cytopathology·2022· 14 citedOpen Access
Severe Graft-Versus-Host Disease Following Solid-Organ Transplant Confirmed by Chimerism Studies and Cytogenetic Analyses
Experimental and Clinical Transplantation·2022
Acute megakaryoblastic leukemia with trisomy 3 and <i><scp>CBFA2T3</scp>::<scp>GLIS2</scp></i>: A case report
Genes Chromosomes and Cancer·2022· 2 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Gregory J. Tsongalis(12), Andrea Ferreira‐Gonzalez(6), Francine B. de Abreu(5), Noah M. Hahn(3), Trinity J. Bivalacqua(3), Ashley E. Ross(3), George J. Netto(3), Jong‐Chul Park(3), Timothy A. Masterson(3), Michael O. Koch(3), Richard Bihrle(3), Richard S. Foster(3), Thomas A. Gardner(3), Kyle McElyea(3), George E. Sandusky(3), Ziyue Liu(3), Elizabeth R. Plimack(3), Richard E. Greenberg(3), Daniel M. Geynisman(3), J. Chuck Harrell(3)